NASDAQ: SGHT
Sight Sciences Inc Stock Ownership - Who owns Sight Sciences?

Insider buying vs selling

Have Sight Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David BadawiChief Technology Officer2025-07-1740,000$0.12
$4.80kBuy
David BadawiChief Technology Officer2025-07-035,679$4.17
$23.70kSell
Jeremy B. HaydenChief Legal Officer2025-07-039,160$4.17
$38.23kSell
Alison BauerleinChief Financial Officer2025-07-0219,260$4.10
$78.93kSell
Matthew LinkChief Commercial Officer2025-07-024,889$4.10
$20.04kSell
Paul BadawiPresident and CEO2025-07-0123,637$4.15
$98.14kSell
Staffan EncrantzDirector2025-06-0627,900$4.22
$117.74kBuy
Staffan EncrantzDirector2025-06-0540,951$4.24
$173.80kBuy
Staffan EncrantzDirector2025-06-0421,674$4.17
$90.42kBuy
Staffan EncrantzDirector2025-06-0325,230$3.97
$100.09kBuy

1 of 6

SGHT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGHT insiders and whales buy or sell their stock.

SGHT Shareholders

What type of owners hold Sight Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Staffan Encrantz12.50%6,464,884$26.25MInsider
Paul Badawi11.58%5,986,943$24.31MInsider
Kck Ltd9.24%4,776,232$19.39MInsider
Kck Ltd8.46%4,374,975$17.76MInstitution
Long Focus Capital Management LLC6.10%3,151,508$12.80MInstitution
D1 Capital Partners LP5.80%3,000,000$12.18MInsider
Jesse Selnick5.09%2,632,927$10.69MInsider
Blackrock Inc4.93%2,550,738$10.36MInstitution
Andrew Offer4.56%2,358,224$9.57MInsider
David Badawi3.62%1,871,025$7.60MInsider

1 of 3

SGHT vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGHT40.80%58.51%Net BuyingNet Buying
ELMD30.72%69.28%Net Selling
CVRX40.41%59.59%Net Buying
INGN70.20%29.80%Net Selling
MASS53.21%46.79%Net BuyingNet Selling

Sight Sciences Stock Ownership FAQ

Who owns Sight Sciences?

Sight Sciences (NASDAQ: SGHT) is owned by 40.80% institutional shareholders, 58.51% Sight Sciences insiders, and 0.69% retail investors. Staffan Encrantz is the largest individual Sight Sciences shareholder, owning 6.46M shares representing 12.50% of the company. Staffan Encrantz's Sight Sciences shares are currently valued at $26.25M.

If you're new to stock investing, here's how to buy Sight Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.